In vivo delivery of RNAi by reducible interfering nanoparticles (iNOPs)

ACS Medicinal Chemistry Letters

Volumn 4, Issue 8, 2013, Pages 720-723

  Baigude, Huricha ^a,b   Su, Jie ^b,d   McCarroll, Joshua ^b,e   Rana, Tariq M ^a,b,c  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^e CHILDREN S CANCER INSTITUTE AUSTRALIA FOR MEDICAL RESEARCH   (Australia)

Author keywords

iNOP; Nanoparticle; reducible nanoparticles; siRNA delivery

Indexed keywords

APOLIPOPROTEIN B; DENDRIMER; MESSENGER RNA; NANOPARTICLE; POLYLYSINE; REDUCIBLE INTERFERING NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; FEASIBILITY STUDY; HUMAN; HUMAN CELL; LIPOSOMAL GENE DELIVERY SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RNA INTERFERENCE; SYNTHESIS; TOXICITY TESTING;

INOPUS; MUS;

EID: 84881406678     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml4001003     Document Type: Article

References (24)

1. Fire, A.; Xu, S.; Montgomery, M. K.; Kostas, S. A.; Driver, S. E.; Mello, C. C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans Nature 1998, 391, 806-811
2. Castanotto, D.; Rossi, J. J. The promises and pitfalls of RNA-interference-based therapeutics Nature 2009, 457, 426-433
3. Aouadi, M.; Tesz, G. J.; Nicoloro, S. M.; Wang, M.; Chouinard, M.; Soto, E.; Ostroff, G. R.; Czech, M. P. Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation Nature 2009, 458, 1180-1184
4. Caplen, N. J.; Parrish, S.; Imani, F.; Fire, A.; Morgan, R. A. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 9742-9747
5. Elbashir, S. M.; Harborth, J.; Lendeckel, W.; Yalcin, A.; Weber, K.; Tuschl, T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 2001, 411, 494-498
6. Rana, T. M. Illuminating the silence: understanding the structure and function of small RNAs Nat. Rev. Mol. Cell Biol. 2007, 8, 23-36
7. Chiu, Y. L.; Rana, T. M. RNAi in human cells: basic structural and functional features of small interfering RNA Mol. Cell 2002, 10, 549-561
8. Palliser, D.; Chowdhury, D.; Wang, Q. Y.; Lee, S. J.; Bronson, R. T.; Knipe, D. M.; Lieberman, J. An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection Nature 2006, 439, 89-94
9. Santel, A.; Aleku, M.; Keil, O.; Endruschat, J.; Esche, V.; Fisch, G.; Dames, S.; Loffler, K.; Fechtner, M.; Arnold, W.; Giese, K.; Klippel, A.; Kaufmann, J. A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium Gene Ther. 2006, 13, 1222-1234
10. Zimmermann, T. S.; Lee, A. C.; Akinc, A.; Bramlage, B.; Bumcrot, D.; Fedoruk, M. N.; Harborth, J.; Heyes, J. A.; Jeffs, L. B.; John, M.; Judge, A. D.; Lam, K.; McClintock, K.; Nechev, L. V.; Palmer, L. R.; Racie, T.; Rohl, I.; Seiffert, S.; Shanmugam, S.; Sood, V.; Soutschek, J.; Toudjarska, I.; Wheat, A. J.; Yaworski, E.; Zedalis, W.; Koteliansky, V.; Manoharan, M.; Vornlocher, H. P.; MacLachlan, I. RNAi-mediated gene silencing in non-human primates Nature 2006, 441, 111-114
11. Soutschek, J.; Akinc, A.; Bramlage, B.; Charisse, K.; Constien, R.; Donoghue, M.; Elbashir, S.; Geick, A.; Hadwiger, P.; Harborth, J.; John, M.; Kesavan, V.; Lavine, G.; Pandey, R. K.; Racie, T.; Rajeev, K. G.; Rohl, I.; Toudjarska, I.; Wang, G.; Wuschko, S.; Bumcrot, D.; Koteliansky, V.; Limmer, S.; Manoharan, M.; Vornlocher, H. P. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs Nature 2004, 432, 173-178
12. Love, K. T.; Mahon, K. P.; Levins, C. G.; Whitehead, K. A.; Querbes, W.; Dorkin, J. R.; Qin, J.; Cantley, W.; Qin, L. L.; Racie, T.; Frank-Kamenetsky, M.; Yip, K. N.; Alvarez, R.; Sah, D. W.; de Fougerolles, A.; Fitzgerald, K.; Koteliansky, V.; Akinc, A.; Langer, R.; Anderson, D. G. Lipid-like materials for low-dose, in vivo gene silencing Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 1864-1869
13. Semple, S. C.; Akinc, A.; Chen, J.; Sandhu, A. P.; Mui, B. L.; Cho, C. K.; Sah, D. W.; Stebbing, D.; Crosley, E. J.; Yaworski, E.; Hafez, I. M.; Dorkin, J. R.; Qin, J.; Lam, K.; Rajeev, K. G.; Wong, K. F.; Jeffs, L. B.; Nechev, L.; Eisenhardt, M. L.; Jayaraman, M.; Kazem, M.; Maier, M. A.; Srinivasulu, M.; Weinstein, M. J.; Chen, Q.; Alvarez, R.; Barros, S. A.; De, S.; Klimuk, S. K.; Borland, T.; Kosovrasti, V.; Cantley, W. L.; Tam, Y. K.; Manoharan, M.; Ciufolini, M. A.; Tracy, M. A.; de Fougerolles, A.; MacLachlan, I.; Cullis, P. R.; Madden, T. D.; Hope, M. J. Rational design of cationic lipids for siRNA delivery Nat. Biotechnol. 2010, 28, 172-176
14. Davis, M. E.; Zuckerman, J. E.; Choi, C. H.; Seligson, D.; Tolcher, A.; Alabi, C. A.; Yen, Y.; Heidel, J. D.; Ribas, A. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles Nature 2010, 464, 1067-1070
15. Baigude, H.; McCarroll, J.; Yang, C. S.; Swain, P. M.; Rana, T. M. Design and creation of new nanomaterials for therapeutic RNAi ACS Chem. Biol. 2007, 2, 237-241
16. Heyes, J.; Palmer, L.; Bremner, K.; MacLachlan, I. Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids J. Controlled Release 2005, 107, 276-287
17. Jeffs, L. B.; Palmer, L. R.; Ambegia, E. G.; Giesbrecht, C.; Ewanick, S.; MacLachlan, I. A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA Pharm. Res. 2005, 22, 362-372
18. Rozema, D. B.; Lewis, D. L.; Wakefield, D. H.; Wong, S. C.; Klein, J. J.; Roesch, P. L.; Bertin, S. L.; Reppen, T. W.; Chu, Q.; Blokhin, A. V.; Hagstrom, J. E.; Wolff, J. A. Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 12982-12987
19. Li, J. M.; Newburger, P. E.; Gounis, M. J.; Dargon, P.; Zhang, X.; Messina, L. M. Local arterial nanoparticle delivery of siRNA for NOX2 knockdown to prevent restenosis in an atherosclerotic rat model Gene Ther. 2010, 17 (10) 1279-1287
20. Kim, S. H.; Jeong, J. H.; Kim, T. I.; Kim, S. W.; Bull, D. A. VEGF siRNA delivery system using arginine-grafted bioreducible poly(disulfide amine) Mol. Pharmaceutics 2009, 6, 718-726
21. Kim, S. H.; Ou, M.; Bull, D. A.; Kim, S. W. Reductive degradation behavior of bioreducible poly(disulfide amine) for enhancing SiRNA efficiency Macromol. Biosci. 2010, 10, 898-905
22. Dunn, S. S.; Tian, S.; Blake, S.; Wang, J.; Galloway, A. L.; Murphy, A.; Pohlhaus, P. D.; Rolland, J. P.; Napier, M. E.; Desimone, J. M. Reductively responsive siRNA-conjugated hydrogel nanoparticles for gene silencing J. Am. Chem. Soc. 2012, 134, 7423-7430
23. Gaumet, M.; Vargas, A.; Gurny, R.; Delie, F. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters Eur. J. Pharm. Biopharm. 2008, 69, 1-9
24. Chiu, Y. L.; Rana, T. M. siRNA function in RNAi: a chemical modification analysis Rna 2003, 9, 1034-1048